Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors
Abstract Blood pressure measurements form a critical component of adverse event monitoring for tyrosine kinase inhibitors, but might also serve as a biomarker for dose titrations. This study explored the impact of various sources of within‐individual variation on blood pressure readings to improve m...
Auteurs principaux: | Maddalena Centanni, Abel Thijs, Ingrid Desar, Mats O. Karlsson, Lena E. Friberg |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Wiley
2023-01-01
|
Collection: | Clinical and Translational Science |
Accès en ligne: | https://doi.org/10.1111/cts.13423 |
Documents similaires
-
Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors
par: Maddalena Centanni, et autres
Publié: (2020-03-01) -
Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic‐pharmacodynamic models
par: Eman I. K. Ibrahim, et autres
Publié: (2023-09-01) -
Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor
par: Sarah Waliany, MD, MS, et autres
Publié: (2019-09-01) -
TYROSINE KINASE INHIBITORS AND INTERFERON
par: Maria Dimou, et autres
Publié: (2014-01-01) -
TYROSINE KINASE INHIBITORS AND PREGNANCY
par: Elisabetta Abruzzese, et autres
Publié: (2014-04-01)